Alexion expansion will double lab floor space
Alexion, AstraZeneca’s Rare Disease group, has announced plans to expand in New Haven by leasing space at the new bioscience tower currently under construction at...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Alexion, AstraZeneca’s Rare Disease group, has announced plans to expand in New Haven by leasing space at the new bioscience tower currently under construction at...
View this email in your browser Weekly Roundup – August 4, 2022 Monday Arvinas announced John Northcott would join their team as the new Chief Commercial Officer. “I...
The Blavatnik Fellowship fifth cohort includes Emmanuel Aisabokhae, RPh, MBAv, Ashoka Madduri, PhD, MBA, and Yi Wang, PhD, MBA, who were selected from an extensive group of applicants...
Pfizer has raised the stakes of the COVID-19 vaccine business. The company has launched a midstage trial of the first in a planned series of next-generation,...
The development compound QXT-101 from Qx Therapeutics has been granted fast-track designation by the FDA for the treatment of Pulmonary Graft Dysfunction (PGD) following lung...
Modifi Biosciences reports that the journal Science has published a critical study validating the company’s novel oncology platform based on new classes of molecules that exploit tumor-associated DNA...
Enko reports $70 million in Series C funding, bringing the company’s overall capital raised to date to $140 million. Mystic-based Enko will use the new funds...
View this email in your browser Weekly Roundup – July 28, 2022 BioLabs is the definitive growth partner for science-based entrepreneurs, empowering companies to accelerate their science,...
Bristol Myers Squibb reports the launch of the Disability Diversity in Clinical Trials initiative. The initiative aims to make recommendations on how to effectively improve access, engagement,...
A “unicorn” is defined as “a private startup company valued at or exceeding $1 billion.” Today there are 1,170 unicorns across all industries – an...